Pages that link to "Q39730973"

The following pages link to An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system (Q39730973):

Displaying 13 items.

• Vaccines in development against West Nile virus (Q26999702) (← links)
• A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations (Q27321020) (← links)
• Plant-made vaccines against West Nile virus are potent, safe, and economically feasible (Q28082778) (← links)
• Large-scale de novo DNA synthesis: technologies and applications (Q34417984) (← links)
• Current trends in West Nile virus vaccine development (Q34788758) (← links)
• Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines (Q36524044) (← links)
• Vaccines and Immunotherapeutics for the Prevention and Treatment of Infections with West Nile Virus (Q37842337) (← links)
• Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases (Q38157590) (← links)
• An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection (Q38866173) (← links)
• Tick-borne encephalitis (TBE): an underestimated risk…still: report of the 14th annual meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE). (Q42982001) (← links)
• Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes (Q43047543) (← links)
• An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults (Q91129614) (← links)
• Twenty Years of Progress Toward West Nile Virus Vaccine Development (Q93155035) (← links)